Answers are grounded in this paper and cite their sources.
Polyacetylene natural products and their glycoside derivatives exhibit diverse biological activities, including antitumor, anti-inflammatory, antioxidant, and immunomodulatory effects, highlighting their considerable potential for applications in pharmaceuticals and functional foods. However, their production from plant sources is constrained by low natural abundance, limited biomass availability, and the complexity of chemical synthesis, making microbial heterologous biosynthesis a promising and sustainable alternative. This review systematically summarizes the biosynthetic mechanisms, key catalytic enzymes, and heterologous reconstruction strategies for polyacetylene natural products. Particular emphasis is placed on major challenges, including the limited availability of key enzymes, inefficient expression of membrane-associated proteins, the toxicity of biosynthetic intermediates, and metabolic network imbalance. Emerging synthetic biology strategies, such as chassis engineering, dynamic metabolic regulation, spatial organization engineering, and artificial intelligence-assisted enzyme design, are also discussed. Finally, future perspectives on the intelligent, efficient, and industrial-scale biomanufacturing of polyacetylene natural products are presented.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: